Sakar Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Sakar Healthcare CEO'su Sanjay Shah, Feb2015 tarihinde atandı, in görev süresi 9.75 yıldır. şirketin hisselerinin 0% doğrudan sahiptir ve bu hisselerin değeri ₹ 31.21K dir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 4.1 yıl ve 4.2 yıldır.

Anahtar bilgiler

Sanjay Shah

İcra Kurulu Başkanı

₹4.8m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	9.8yrs
CEO sahipliği	0.0005%
Yönetim ortalama görev süresi	4.1yrs
Yönetim Kurulu ortalama görev süresi	4.2yrs

Son yönetim güncellemeleri

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Mar 02

Recent updates

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Mar 23

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Mar 02

Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Feb 08

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Jan 10

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Dec 14

Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

Nov 22

CEO Tazminat Analizi

Sanjay Shah'un ücretlendirmesi Sakar Healthcare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	₹124m
Jun 30 2024	n/a	n/a	₹112m
Mar 31 2024	₹5m	n/a	₹117m
Dec 31 2023	n/a	n/a	₹125m
Sep 30 2023	n/a	n/a	₹144m
Jun 30 2023	n/a	n/a	₹127m
Mar 31 2023	₹5m	n/a	₹128m
Dec 31 2022	n/a	n/a	₹178m
Sep 30 2022	n/a	n/a	₹139m
Jun 30 2022	n/a	n/a	₹144m
Mar 31 2022	₹5m	n/a	₹152m
Dec 31 2021	n/a	n/a	₹80m
Sep 30 2021	n/a	n/a	₹97m
Jun 30 2021	n/a	n/a	₹118m
Mar 31 2021	₹2m	n/a	₹107m
Dec 31 2020	n/a	n/a	₹118m
Sep 30 2020	n/a	n/a	₹122m
Jun 30 2020	n/a	n/a	₹106m
Mar 31 2020	₹2m	₹2m	₹96m
Dec 31 2019	n/a	n/a	₹88m
Sep 30 2019	n/a	n/a	₹86m
Jun 30 2019	n/a	n/a	₹78m
Mar 31 2019	₹2m	₹2m	₹67m

Tazminat ve Piyasa: Sanjay 'nin toplam tazminatı ($USD 57.08K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 42.81K ).

Tazminat ve Kazançlar: Sanjay 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Sanjay Shah (65 yo)

9.8yrs

Görev süresi

₹4,800,000

Tazminat

Mr. Sanjay Surendra Shah has been Managing Director of Sakar Healthcare Limited since February 1, 2015. Mr. Shah serves as an Executive Director of Sakar Healthcare Limited since March 26, 2004 and serves...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sanjay Shah	Chairman & MD	9.8yrs	₹4.80m	0.00046% ₹ 31.2k
Aarsh Shah	Joint MD & Executive Director	12.4yrs	₹3.60m	0.000060% ₹ 4.1k
Sunil Marathe	Technical Director & Whole Time Director	less than a year	₹1.20m	Veri yok
Dharmesh Thaker	Chief Financial Officer	3.1yrs	Veri yok	Veri yok
Bharat Soni	Company Secretary & Compliance Officer	4.1yrs	Veri yok	Veri yok

4.1yrs

Ortalama Görev Süresi

34yo

Ortalama Yaş

Deneyimli Yönetim: SAKAR 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 4.1 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Sanjay Shah	Chairman & MD	20.7yrs	₹4.80m	0.00046% ₹ 31.2k
Aarsh Shah	Joint MD & Executive Director	12.4yrs	₹3.60m	0.000060% ₹ 4.1k
Sunil Marathe	Technical Director & Whole Time Director	less than a year	₹1.20m	Veri yok
Vishalakshi Chandramouli	Non-Executive Non-Independent Director	1.2yrs	Veri yok	Veri yok
Shailesh Patel	Non-Executive Independent Director	9.6yrs	Veri yok	Veri yok
Prashant Srivastav	Independent Non-Executive Director	9.6yrs	Veri yok	Veri yok
Hemendrakumar Shah	Independent Non-Executive Director	4.2yrs	Veri yok	Veri yok
Khyati Shah	Non-Executive Independent Director	less than a year	Veri yok	Veri yok
Jignesh Parikh	Non-Executive Independent Director	less than a year	Veri yok	Veri yok

4.2yrs

Ortalama Görev Süresi

54yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SAKAR 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4.2 yıldır).

Sakar Healthcare Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Sakar Healthcare Limited, Annual General Meeting, Sep 21, 2024

Insufficient new directors

Sakar Healthcare Limited, Annual General Meeting, Sep 21, 2023

Sakar Healthcare Limited, Annual General Meeting, Sep 20, 2022

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Recent updates

Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think

Second quarter 2025 earnings released: EPS: ₹2.17 (vs ₹1.68 in 2Q 2024)

New minor risk - Shareholder dilution

First quarter 2025 earnings released: EPS: ₹1.10 (vs ₹1.46 in 1Q 2024)

Sakar Healthcare Limited, Annual General Meeting, Sep 21, 2024

Full year 2024 earnings released: EPS: ₹5.64 (vs ₹6.86 in FY 2023)

Investor sentiment deteriorates as stock falls 15%

Third quarter 2024 earnings released: EPS: ₹0.98 (vs ₹2.16 in 3Q 2023)

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Second quarter 2024 earnings released: EPS: ₹1.68 (vs ₹1.01 in 2Q 2023)

Insufficient new directors

Investor sentiment improves as stock rises 20%

New major risk - Financial position

First quarter 2024 earnings released: EPS: ₹1.46 (vs ₹1.65 in 1Q 2023)

New major risk - Share price stability

Sakar Healthcare Limited announced that it expects to receive INR 599.999123 million in funding from Tata Investment Corporation Limited

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 27%

Sakar Healthcare Limited, Annual General Meeting, Sep 21, 2023

Full year 2023 earnings released: EPS: ₹6.59 (vs ₹8.90 in FY 2022)

Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?

Third quarter 2023 earnings released: EPS: ₹2.16 (vs ₹0.07 in 3Q 2022)

Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors

Investor sentiment improved over the past week

Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?

Second quarter 2023 earnings released: EPS: ₹1.01 (vs ₹1.44 in 2Q 2022)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: ₹1.65 (vs ₹1.80 in 1Q 2022)

Sakar Healthcare Limited, Annual General Meeting, Sep 20, 2022

Investor sentiment improved over the past week

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Full year 2022 earnings released: EPS: ₹8.73 (vs ₹7.09 in FY 2021)

Investor sentiment improved over the past week

Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹1.44 (vs ₹3.04 in 2Q 2021)

Full year 2021 earnings released: EPS ₹7.09 (vs ₹6.43 in FY 2020)

Investor sentiment deteriorated over the past week

With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹6.87 (vs ₹6.43 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today

Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares

Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?

Third quarter 2021 earnings released: EPS ₹1.20 (vs ₹1.48 in 3Q 2020)

Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?

Investor sentiment improved over the past week

New 90-day high: ₹107

Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock

Market bids up stock over the past week

New 90-day high: ₹91.65

Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?

First half earnings released

Market pulls back on stock over the past week

New 90-day high: ₹84.85

New 90-day high - ₹78.70

First quarter earnings released

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri